Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Autolus Therapeutics plc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 111 | 1 | 101 | −9 |
| Shares | 178.2M | 4.44M | 178.6M | +4.92M (+2.8%) |
| Value | $620.0M | $15.4M | $648.5M | +$43.9M (+7.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Autolus Therapeutics plc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 4,425,746 | $16.1M | 0.00% |
| Gsa Capital Partners LLP | 298,086 | $1.08M | 0.08% |
| Herbst Group, LLC | 25,000 | $90.8K | 0.06% |
| Altfest L J & Co Inc | 21,820 | $79.0K | 0.01% |
| Capstone Investment Advisors, LLC | 13,951 | $50.6K | 0.00% |
| Golden State Equity Partners | 3,900 | $14.2K | 0.00% |
| Barclays PLC | 993 | $3.60K | 0.00% |
Sold out (16)
Institutions that held Autolus Therapeutics plc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Commodore Capital LP | 1,178,723 | $4.10M |
| Exome Asset Management LLC | 839,472 | $2.92M |
| Driehaus Capital Management LLC | 668,349 | $2.33M |
| LGT Capital Partners Ltd. | 370,000 | $1.29M |
| Prelude Capital Management, LLC | 266,692 | $928.1K |
| Jump Financial, LLC | 212,294 | $738.8K |
| Victory Capital Management Inc | 132,580 | $461.4K |
| Rafferty Asset Management, LLC | 99,319 | $345.6K |
| Jane Street Group, LLC | 93,275 | $324.6K |
| Allianz Asset Management GmbH | 38,700 | $134.7K |
| Dynamic Technology Lab Private Ltd | 27,395 | $95.0K |
| Balyasny Asset Management LLC | 22,242 | $77.4K |
| Squarepoint Ops LLC | 20,589 | $71.7K |
| Fred Alger Management, LLC | 10,262 | $35.7K |
| New York State Common Retirement Fund | 10,111 | $35.2K |
| Itau Unibanco Holding S.A. | 3,763 | $13.1K |
Not filed for Q3 2024 yet (1)
Institutions that held Autolus Therapeutics plc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 4,436,102 | $15.4M |